MERCK & CO., INC. (MRK)
Clinical trial NCT06112353 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-07-31 → 2026-06-30 3. primary completion date: 2026-07-01 → 2026-03-04 4. enrollment: 128 → 132 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical